Standout Papers

Donanemab in Early Alzheimer’s Disease 2021 2026 2022 2024891
  1. Donanemab in Early Alzheimer’s Disease (2021)
    Mark A. Mintun, Albert Lo et al. New England Journal of Medicine

Immediate Impact

4 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout
2 intermediate papers

Works of Cynthia Evans being referenced

Donanemab in Early Alzheimer’s Disease
2021 Standout
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging
2021

Author Peers

Author Last Decade Papers Cites
Cynthia Evans 842 458 306 39 1.5k
Gregory Klein 1006 584 286 75 2.0k
Yuki Mukai 773 286 379 42 1.3k
Chera L. Maarouf 772 298 130 34 1.3k
Kristin R. Wildsmith 822 245 158 39 1.5k
Zhenyu Zhong 757 194 156 50 1.4k
Martin Koller 672 333 169 22 1.3k
Alessandra Piccini 1022 214 270 37 2.1k
Rawan Tarawneh 646 373 109 29 1.4k
J. Bohl 723 166 191 45 1.6k
Vijay K. Ramanan 668 447 96 56 1.4k

All Works

Loading papers...

Rankless by CCL
2026